These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31408457)

  • 1. Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.
    McAvoy KM; Rajamohamed Sait H; Marsh G; Peterson M; Reynolds TL; Gagnon J; Geisler S; Leach P; Roberts C; Cahir-McFarland E; Ransohoff RM; Crotti A
    PLoS One; 2019; 14(8):e0220125. PubMed ID: 31408457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model.
    Ponnusamy M; Wang S; Yuksel M; Hansen MT; Blazier DM; McMillan JD; Zhang X; Dammer EB; Collier L; Thinakaran G
    Brain; 2023 Apr; 146(4):1561-1579. PubMed ID: 36059072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIN1 favors the spreading of Tau via extracellular vesicles.
    Crotti A; Sait HR; McAvoy KM; Estrada K; Ergun A; Szak S; Marsh G; Jandreski L; Peterson M; Reynolds TL; Dalkilic-Liddle I; Cameron A; Cahir-McFarland E; Ransohoff RM
    Sci Rep; 2019 Jul; 9(1):9477. PubMed ID: 31263146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr
    Sartori M; Mendes T; Desai S; Lasorsa A; Herledan A; Malmanche N; Mäkinen P; Marttinen M; Malki I; Chapuis J; Flaig A; Vreulx AC; Ciancia M; Amouyel P; Leroux F; Déprez B; Cantrelle FX; Maréchal D; Pradier L; Hiltunen M; Landrieu I; Kilinc D; Herault Y; Laporte J; Lambert JC
    Acta Neuropathol; 2019 Oct; 138(4):631-652. PubMed ID: 31065832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bin1 antibody lowers the expression of phosphorylated Tau in Alzheimer's disease.
    Thomas S; Hoxha K; Tran A; Prendergast GC
    J Cell Biochem; 2019 Oct; 120(10):18320-18331. PubMed ID: 31211444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease risk gene
    Voskobiynyk Y; Roth JR; Cochran JN; Rush T; Carullo NV; Mesina JS; Waqas M; Vollmer RM; Day JJ; McMahon LL; Roberson ED
    Elife; 2020 Jul; 9():. PubMed ID: 32657270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's disease.
    Zhou Y; Hayashi I; Wong J; Tugusheva K; Renger JJ; Zerbinatti C
    PLoS One; 2014; 9(7):e103187. PubMed ID: 25051234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant accrual of BIN1 near Alzheimer's disease amyloid deposits in transgenic models.
    De Rossi P; Andrew RJ; Musial TF; Buggia-Prevot V; Xu G; Ponnusamy M; Ly H; Krause SV; Rice RC; de l'Estoile V; Valin T; Salem S; Despa F; Borchelt DR; Bindokas VP; Nicholson DA; Thinakaran G
    Brain Pathol; 2019 Jul; 29(4):485-501. PubMed ID: 30506549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: neuronal and astrocyte BIN1 are implicated in tau pathology.
    Taga M; Petyuk VA; White C; Marsh G; Ma Y; Klein HU; Connor SM; Kroshilina A; Yung CJ; Khairallah A; Olah M; Schneider J; Karhohs K; Carpenter AE; Ransohoff R; Bennett DA; Crotti A; Bradshaw EM; De Jager PL
    Mol Neurodegener; 2020 Jul; 15(1):44. PubMed ID: 32727516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration.
    Wang HF; Wan Y; Hao XK; Cao L; Zhu XC; Jiang T; Tan MS; Tan L; Zhang DQ; Tan L; Yu JT;
    J Alzheimers Dis; 2016 Mar; 52(1):179-90. PubMed ID: 27003210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology.
    Chapuis J; Hansmannel F; Gistelinck M; Mounier A; Van Cauwenberghe C; Kolen KV; Geller F; Sottejeau Y; Harold D; Dourlen P; Grenier-Boley B; Kamatani Y; Delepine B; Demiautte F; Zelenika D; Zommer N; Hamdane M; Bellenguez C; Dartigues JF; Hauw JJ; Letronne F; Ayral AM; Sleegers K; Schellens A; Broeck LV; Engelborghs S; De Deyn PP; Vandenberghe R; O'Donovan M; Owen M; Epelbaum J; Mercken M; Karran E; Bantscheff M; Drewes G; Joberty G; Campion D; Octave JN; Berr C; Lathrop M; Callaerts P; Mann D; Williams J; Buée L; Dewachter I; Van Broeckhoven C; Amouyel P; Moechars D; Dermaut B; Lambert JC;
    Mol Psychiatry; 2013 Nov; 18(11):1225-34. PubMed ID: 23399914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Bin1 Promotes the Propagation of Tau Pathology.
    Calafate S; Flavin W; Verstreken P; Moechars D
    Cell Rep; 2016 Oct; 17(4):931-940. PubMed ID: 27760323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging integrator 1 fragment accelerates tau aggregation and propagation by enhancing clathrin-mediated endocytosis in mice.
    Zhang X; Zou L; Tang L; Xiong M; Yan XX; Meng L; Chen G; Xiong J; Nie S; Zhang Z; Chen Q; Zhang Z
    PLoS Biol; 2024 Jan; 22(1):e3002470. PubMed ID: 38206965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominant expression of Alzheimer's disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts.
    De Rossi P; Buggia-Prévot V; Clayton BL; Vasquez JB; van Sanford C; Andrew RJ; Lesnick R; Botté A; Deyts C; Salem S; Rao E; Rice RC; Parent A; Kar S; Popko B; Pytel P; Estus S; Thinakaran G
    Mol Neurodegener; 2016 Aug; 11(1):59. PubMed ID: 27488240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BIN1 in the Pursuit of Ousting the Alzheimer's Reign: Impact on Amyloid and Tau Neuropathology.
    Kaur I; Behl T; Sundararajan G; Panneerselvam P; Vijayakumar AR; Senthilkumar GP; Venkatachalam T; Jaglan D; Yadav S; Anwer K; Fuloria NK; Sehgal A; Gulati M; Chigurupati S
    Neurotox Res; 2023 Dec; 41(6):698-707. PubMed ID: 37847429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
    Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
    Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
    Saul A; Sprenger F; Bayer TA; Wirths O
    Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory.
    Franzmeier N; Rubinski A; Neitzel J; Ewers M;
    Nat Commun; 2019 Apr; 10(1):1766. PubMed ID: 30992433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mechanistic Role of Bridging Integrator 1 (BIN1) in Alzheimer's Disease.
    Gao P; Ye L; Cheng H; Li H
    Cell Mol Neurobiol; 2021 Oct; 41(7):1431-1440. PubMed ID: 32719966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.